Bioinformatics in IVD Market to Reach $133.49B by 2030 at 6% CAGR
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Does The Market Size Of The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Compare Between 2026 And 2030?
The market size for bioinformatics in in-vitro diagnostics (IVD) testing has shown significant growth over recent years. This market is anticipated to increase from $98.89 billion in 2025 to $105.59 billion by 2026, achieving a compound annual growth rate (CAGR) of 6.8%. The expansion observed historically can be attributed to factors such as the increase in molecular diagnostic testing volumes, the heightened adoption of next-generation sequencing in diagnostics, the proliferation of centralized diagnostic laboratories, the improved availability of advanced diagnostic hardware, and the surging utilization of data-driven clinical decision support.
The bioinformatics in in-vitro diagnostics (ivd) testing market size is expected to experience significant expansion over the next few years. It is projected to reach $133.49 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.0%. This anticipated growth during the forecast period can be attributed to several factors, including the increasing demand for precision diagnostics, the expansion of personalized medicine diagnostics, rising investments in AI-enabled diagnostic platforms, the growing use of cloud-based diagnostic analytics, and increasing regulatory acceptance of digital diagnostics. Major trends anticipated within this forecast period include the increasing use of AI-based diagnostic interpretation software, a rising adoption of cloud-enabled IVD bioinformatics platforms, the growing integration of molecular and clinical data sets, the expansion of companion diagnostics analytics, and an enhanced focus on real-time diagnostic data processing.
Access Your Free Sample Report For In-Depth Market Analysis:
What Key Drivers Are Fueling The Growth Of The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market?
A projected rise in cancer cases is anticipated to boost the bioinformatics sector within the IVD testing market in the coming period. Cancer encompasses a range of illnesses marked by uncontrolled cellular proliferation capable of spreading and invading different areas of the body. This growing incidence of cancer is attributed to diverse elements, including exposure, lifestyle choices, and environmental factors. Within IVD testing, bioinformatics revolutionizes cancer diagnosis by delivering accurate, tailored, and exhaustive genetic data, thereby improving early diagnosis, guiding therapeutic choices, and bettering patient results. As an illustration, the World Health Organization, a Switzerland-based specialized agency of the United Nations, reported in February 2024 that an excess of 35 million new cancer diagnoses is forecasted for 2050. Consequently, the escalating occurrence of cancer acts as a key driver for bioinformatics in the IVD testing market.
How Is The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Organized By Segment Classification?
The bioinformatics in in-vitro diagnostics (ivd) testing market covered in this report is segmented –
1) By Component: Hardware, Software
2) By Type Of Test: Blood Based Tests, Tissue Based Tests
3) By Application: Cardiovascular Diseases, Chronic Diseases, Diabetes, Cancer, Other Applications
Subsegments:
1) By Hardware: Analyzers, Laboratory Equipment, Data Storage Devices, Sensors And Detectors, Workstations And Data Processing Hardware
2) By Software: Bioinformatics Platforms, Data Management and Integration Software, Analytics And Interpretation Software, Cloud-Based Software Solutions, AI-Based Software For Diagnostics
What Trends Are Influencing The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market?
Major companies engaged in bioinformatics within the IVD testing market are prioritizing the development of innovative solutions, such as next-generation sequencing (NGS) technology, to bolster the detection and analysis of genetic mutations, elevate diagnostic accuracy, and facilitate personalized medicine approaches. Next-generation sequencing (NGS) is a sophisticated, high-throughput technique that enables the rapid sequencing of whole genomes or specific segments of DNA and RNA, thereby allowing for extensive genetic analysis. For example, in January 2024, QIAGEN Digital Insights, the bioinformatics arm of the Netherlands-based molecular diagnostics company QIAGEN, launched LightSpeed, an ultra-fast NGS secondary-analysis software accelerator integrated into its CLC Genomics Workbench Premium platform. The LightSpeed module enables laboratories to process somatic cancer NGS data with unparalleled speed, converting raw sequencing files (FASTQ) into variant calls (VCF) in mere minutes, simultaneously reducing the cost per sample. LightSpeed supports high-throughput cancer panels and is compatible with both cloud-based and on-premises workflows, empowering bioinformatics teams to swiftly analyze multiple tumor genes and biomarkers from a single sample to inform precision oncology decision-making.
Who Are The Industry Participants Involved In The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market?
Major companies operating in the bioinformatics in in-vitro diagnostics (ivd) testing market are Illumina Inc, Thermo Fisher Scientific Inc, QIAGEN N.V, Agilent Technologies Inc, PerkinElmer Inc, Roche Holding AG, BGI Genomics Co Ltd, DNAnexus Inc, Seven Bridges Genomics Inc, Dassault Systèmes SE (BIOVIA), Genedata AG, Partek Inc, Data4Cure Inc, Ontoforce NV, Geneious (Biomatters), SoftGenetics LLC, Eagle Genomics Ltd, Wuxi NextCODE Genomics, Bio-Rad Laboratories Inc, Eurofins Scientific SE
Get The Full Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Report:
Which Region Dominates The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market By Market Share?
North America was the largest region in the bioinformatics in in-vitro diagnostics (IVD) testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioinformatics in in-vitro diagnostics (ivd) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market 2026, By The Business Research Company
Biologics Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report
In Vitro Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report
In Vitro Diagnostics Ivd Quality Control Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
